PharmiNews

Directory of Pharma Companies and News

Company Profile

Ablynx

Ablynx logo
Category
Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments, which combine the advantages of conventional antibody drugs with some of the features of small-molecule drugs. Ablynx is dedicated to creating new medicines which will make a real difference to society. Today, the Company has more than 30 proprietary and partnered programmes in development in various therapeutic areas including inflammation, haematology, oncology and respiratory disease. The Company has collaborations with multiple pharmaceutical companies including AbbVie, Boehringer Ingelheim, Eddingpharm, Merck & Co. Inc., Merck Serono and Novartis. The Company is headquartered in Ghent, Belgium.
Keywords:

Ablynx News

Brought to you by PharmiWeb.com - Latest Jobs in Pharma
E_CORE_WARNING Error in file »Unknown« at line 0: PHP Startup: Invalid library (appears to be a Zend Extension, try loading using zend_extension=opcache.so from php.ini)